TTR and AL amyloidosis: AL amyloidosis often necessitates immediate and aggressive chemotherapy to suppress the underlying plasma cell disorder [1, 2], while the management of ATTR amyloidosis may involve TTR stabilizers, gene-silencing therapies, or organ transplantation, particularly in advanced cases [3–5].